SBC Medical Group Holdings Incorporated Net Income
SBC Medical Group Holdings Incorporated (SBC) reported Net Income of $10.69 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated net income (loss) attributable to parent for the quarter ending 2026-06-30 was $10.69M, a 334.98% increase year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to parent for the quarter ending 2026-03-31 was $11.31M, a 47.41% decline year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to parent for the quarter ending 2025-12-31 was $14.20M, a 117.16% increase year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to parent for the quarter ending 2025-09-30 was $12.82M, a 352.70% increase year-over-year.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to parent for fiscal 2025 was $50.99M, a 9.38% increase from fiscal 2024.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to parent for fiscal 2024 was $46.61M, a 18.40% increase from fiscal 2023.
- SBC Medical Group Holdings Incorporated net income (loss) attributable to parent for fiscal 2023 was $39.37M.
| Period end | Net Income (Loss) Attributable to Parent 1 month | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 4 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 7 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 10 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.69M 10-Q · filed 2026-08-13 | $22.00M 10-Q · filed 2026-08-13 | $36.20M derived: sum of 3 quarters · filed 2026-08-13 | $49.03M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2026-03-31 | $11.31M 10-Q · filed 2026-05-14 | $25.51M derived: sum of 2 quarters · filed 2026-05-14 | $38.33M derived: sum of 3 quarters · filed 2026-05-14 | $40.79M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-12-31 | $14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $27.02M derived: sum of 2 quarters · filed 2026-03-27 | $29.48M derived: sum of 3 quarters · filed 2026-08-13 | $50.99M 10-K · filed 2026-03-27 | ||||||||
| 2025-09-30 | $12.82M 10-Q · filed 2025-11-14 | $15.28M derived: sum of 2 quarters · filed 2026-08-13 | $36.79M 10-Q · filed 2025-11-14 | $43.32M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-06-30 | $2.46M 10-Q · filed 2026-08-13 | $23.96M 10-Q · filed 2026-08-13 | $30.50M derived: sum of 3 quarters · filed 2026-08-13 | $33.33M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||
| 2025-03-31 | $21.50M 10-Q · filed 2026-05-14 | $28.04M derived: sum of 2 quarters · filed 2026-05-14 | $30.87M derived: sum of 3 quarters · filed 2026-05-14 | $49.36M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||
| 2024-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $9.37M derived: sum of 2 quarters · filed 2026-03-27 | $27.86M derived: sum of 3 quarters · filed 2026-03-27 | $46.61M 10-K · filed 2026-03-27 | ||||||||
| 2024-09-30 | $2.83M 10-Q · filed 2025-11-14 | $21.32M derived: sum of 2 quarters · filed 2025-11-14 | $40.08M 10-Q · filed 2025-11-14 | $54.42M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-06-30 | $18.48M 10-Q · filed 2025-08-13 | -$308.27K 10-Q · filed 2024-08-16 | $37.24M 10-Q · filed 2025-08-13 | -$600.81K 10-Q · filed 2024-08-16 | $51.58M derived: sum of 3 quarters · filed 2025-08-13 | $59.94M derived: sum of 4 quarters · filed 2025-08-13 | ||||||
| 2024-03-31 | $18.76M 10-Q · filed 2025-05-15 | -$292.55K 10-Q · filed 2024-05-20 | $33.10M derived: sum of 2 quarters · filed 2025-05-15 | $41.46M derived: sum of 3 quarters · filed 2025-05-15 | $41.65M derived: sum of 4 quarters · filed 2025-05-15 | |||||||
| 2023-12-31 | $14.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $22.70M derived: sum of 2 quarters · filed 2025-03-28 | $22.90M derived: sum of 3 quarters · filed 2025-03-28 | $39.37M 10-K · filed 2025-03-28 | $339.77K 10-K · filed 2024-03-19 | |||||||
| 2023-09-30 | $8.36M 10-Q · filed 2024-11-13 | -$104.53K 10-Q · filed 2023-11-14 | $8.55M derived: sum of 2 quarters · filed 2024-11-13 | $25.03M 10-Q · filed 2024-11-13 | $705.58K 10-Q · filed 2023-11-14 | |||||||
| 2023-06-30 | $196.79K 10-Q · filed 2024-08-16 | $810.12K 10-Q · filed 2024-08-16 | ||||||||||
| 2023-03-31 | $613.33K 10-Q · filed 2024-08-16 | |||||||||||
| 2022-12-31 | $552.81K 10-K · filed 2024-03-19 | |||||||||||
| 2022-09-30 | -$11.42K 10-Q · filed 2023-11-14 | -$12.70K derived: sum of 2 quarters · filed 2023-11-14 | -$13.04K 10-Q · filed 2023-11-14 | |||||||||
| 2022-06-30 | -$1.28K 10-Q · filed 2023-11-14 | -$1.62K 10-Q · filed 2023-08-14 | ||||||||||
| 2022-03-31 | -$339.00 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |